Overview
What is Versiti Wisconsin Inc?
Versiti Wisconsin Inc, based in Milwaukee, Wisconsin, is a leading blood health innovator with a mission to enhance lives through discovery, diagnosis, and treatment. With 1,301 employees, Versiti Wisconsin operates the Comprehensive Center for Bleeding Disorders under a federal subaward agreement of the Social Security Act. The center offers essential services to patients with bleeding and clotting disorders and their families, providing access to discounted specialty pharmaceuticals through the 340B Drug Discount Program. These funds are allocated to activities and expenditures furthering eligible projects and program objectives, such as patient care, education, support services, approved grant research, and other costs. Versiti distributes these specialty pharmacy products to both home care patients and hospital systems. In 2022, they supplied 17,695 vials of these vital products.
Official website here: www.versiti.org
Is Versiti Wisconsin Inc legitimate?
Versiti Wisconsin Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Versiti Wisconsin Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $3,476,227
Professional Fundraising Fees: $0
Other Salaries and Wages: $62,360,026
For more financial information, click here
Official website here: www.versiti.org
What is the mission statement of Versiti Wisconsin Inc?
Versiti Wisconsin Inc, as a blood health innovator, enhances lives through discovery, diagnosis, and treatment. By integrating science, medicine, and service, Versiti expands the frontiers of patient health. The organization operates the Comprehensive Center for Bleeding Disorders, providing essential services to bleeding and clotting disorder patients and their families. As a covered entity under the Federal 340B Drug Discount Program, Versiti is eligible to access specialty pharmaceuticals at discounted pricing. The income generated from pharmaceutical net sales is restricted to activities and expenditures that further eligible projects and program objectives, such as patient care, education, support services, approved grant research, and other costs. Versiti provides these specialty pharmacy products to home care patients and hospital systems, with 17,695 vials distributed during 2022.
Official website here: www.versiti.org
Who is the CEO of Versiti Wisconsin Inc?
Chris Miskel is the President & Ceo of Versiti Wisconsin Inc. The CEO's salary of Versiti Wisconsin Inc is $567,313 and their total compensation is $1,401,640.
Official website here: www.versiti.org
What is the revenue of Versiti Wisconsin Inc?
Who are the executives of Versiti Wisconsin Inc and what are their salaries?
The average compensation at Versiti Wisconsin Inc during 2022 was $50,604. There are 1,301 employees and 284 volunteers at Versiti Wisconsin Inc.
Here are 33 key members and their salaries (Versiti Wisconsin Inc's CEO's salary is $567,313 and their total compensation is $1,401,640):
- Chris Miskel (President & Ceo) [Trustee/Director]
- Brian Bautista (Evp & Chief Operating Officer)
- Bart Reuter (Evp & General Counsel)
- Gitesh Dubal (Evp & Chief Marketing Officer)
- Anthony Watkins (Evp & Chief Financial Officer)
- Michael Deininger Md (Evp & Chief Scientific Officer)
- Bradley Pietz (Evp & Chief Laboratory Officer)
- James Weidner (Evp & Chief Hr Officer)
- Peter Newman Phd (Vp Research & Assoc Dir Bri)
- Lynne Briggs (Vp & Chief Information Officer)
- Matthew Anderson Md (Vp & Diagnostic Lab Med Dir)
- Lynn M Malec Md (Senior Medical Director)
- Kathleen E Puca Md (Senior Medical Director)
- Bob Montgomery Md (Senior Investigator)
- Alexandra Pieper (Vp & Chief Quality Officer)
- Margaret Mcelligott (Former Vp & Chief Quality Officer)
- Barbara Bryant (Evp & Chief Med Off - As Of 11/2022)
- Joshua J Field Md (Sr Med Dir(Int Ch Med Off)-Thru 4/22)
- Thomas Hauske Jr (Chair) [Trustee/Director]
- Fred Geilfuss (Vice Chair; Legal Advisor) [Trustee/Director]
- Sherry Husa (Secretary) [Trustee/Director]
- John Perras (Treasurer) [Trustee/Director]
- Coreen Dicus-Johnson Jd (Board Member) [Trustee/Director]
- David Ginsburg Md (Board Member) [Trustee/Director]
- Gail Hanson (Board Member) [Trustee/Director]
- Dale Kent (Board Member) [Trustee/Director]
- Robert H Manegold (Board Member) [Trustee/Director]
- Jefferey S Mcdonald (Board Member) [Trustee/Director]
- Ron Miller (Board Member) [Trustee/Director]
- Kathy Thornton-Bias (Board Member) [Trustee/Director]
- Greg Wesley (Board Member) [Trustee/Director]
- L Alan Whaley (Board Member) [Trustee/Director]
- Peter Ziegler (Board Member) [Trustee/Director]
Official website here: www.versiti.org
Where can I find the form 990 for Versiti Wisconsin Inc?
The Versiti Wisconsin Inc’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.versiti.org
Learn more at the official website: www.versiti.org
Mission Statement of Versiti Wisconsin Inc
Versiti Wisconsin, a pioneering blood health innovator, enhances lives through the integration of science, medicine, and service. Dedicated to discovery, diagnosis, and treatment, Versiti expands the frontiers of patient health. The organization's primary focus is on individuals with bleeding and clotting disorders and their families.
Versiti operates the Comprehensive Center for Bleeding Disorders (CCBD), a covered entity under a federal subaward agreement of the Social Security Act. CCBD is committed to providing critical services to patients suffering from bleeding and clotting disorders. As a participant in the 340B Drug Discount Program, Versiti is eligible to access specialty pharmaceuticals at discounted pricing. This program income is restricted to activities and expenditures that further eligible projects and program objectives, including patient care, education, support services, approved grant research, and other costs. Versiti distributes these specialty pharmacy products to home care patients and hospital systems. In 2022, 17,695 vials of specialty pharmacy products were dispensed by Versiti.
Impact
This information is meant to be a general summary of Versiti Wisconsin Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
Versiti Wisconsin Inc, through its comprehensive Center for Bleeding Disorders (CCBD) and participation in the federal 340B Drug Discount Program, plays a crucial role in enhancing the lives of bleeding and clotting disorder patients and their families. By providing critical services, specialty pharmacy products, patient care, education, support services, and approved grant research, Versiti contributes significantly to the well-being and treatment of individuals facing these health challenges. The impact of Versiti's work extends beyond Milwaukee to reach a broad population in Wisconsin, ultimately advancing the frontiers of patient health through scientific innovation and compassionate care.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
PHARMACY
Revenue
$54,057,206
BLOOD SERVICES
Revenue
$51,795,488
DIAGNOSTIC LABORATORIES
Revenue
$40,658,823
ORGAN AND TISSUE DONATION
Revenue
$19,999,163
MEDICAL SERVICES
Revenue
$12,039,912
Organization Details
Founding Year
1947
Phone
(414) 933-5000
Principal Officer
Chris Miskel
Main Address
PO BOX 2178, MILWAUKEE, WI, 532012178
Website
www.versiti.org
NTEE Category
Code: E60 - Health
If you are a representative of Versiti Wisconsin Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.